{"id":31801,"date":"2014-09-23T10:50:01","date_gmt":"2014-09-23T14:50:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=31801"},"modified":"2014-09-23T10:50:01","modified_gmt":"2014-09-23T14:50:01","slug":"merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801","title":{"rendered":"Merck &#038; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 <strong>Merck &amp; Co., Inc. (NYSE:MRK),<\/strong> the Germany-based pharmaceutical company, has offered to buy <strong>Sigma-Aldrich Corporation (NASDAQ:SIAL)<\/strong> for $17 billion.<\/p>\n<p style=\"text-align: justify;\"><strong>Terms Of Deal<\/strong><\/p>\n<p style=\"text-align: justify;\">Sigma-Aldrich Corporation (NASDAQ:SIAL) is among the biggest manufacturers of chemicals and biological substances used in labs. The life science and high-technology Company had recorded sales of as much as $2.7 billion in 2013. Almost 50% of the company\u2019s revenues are derived from educational laboratories, medical companies and industrial manufacturers which conduct research and development.<\/p>\n<p style=\"text-align: justify;\">Merck seeks to buy the company in a $140 per share cash transaction. The quoted figure marks a premium of 37% to Sigma-Aldrich\u2019s closing price last week on Friday. According to industry experts, the premium offer made by Merck &amp; Co., Inc. (NYSE:MRK) is too high for Sigma-Aldrich. As stated in The New York Times\u2019 <a href=\"http:\/\/dealbook.nytimes.com\/2014\/09\/22\/merck-of-germany-to-acquire-sigma-aldrich-for-17-billion\/?_php=true&amp;_type=blogs&amp;partner=yahoofinance&amp;_r=0\" target=\"_blank\">article<\/a>, the acquisition would increase Merck\u2019s presence in the U.S. In addition, it would also allow the company to expand to Asian markets.<\/p>\n<p style=\"text-align: justify;\"><strong>A Strong Move<\/strong><\/p>\n<p style=\"text-align: justify;\">According to Wall Street Journal\u2019s <a href=\"http:\/\/online.wsj.com\/articles\/germanys-merck-to-buy-sigma-aldrich-for-17-billion-1411381734\" target=\"_blank\">article<\/a>, the acquisition is a part of Merck\u2019s recent efforts to decrease its reliance on developing novel drugs. This is because currently Merck is mostly dependent on its biggest pharmaceutical business, Merck Serono. The unit is in itself chiefly reliant on only two major drugs, namely multiple sclerosis treatment Rebif and cancer therapy Erbitux. Merck &amp; Co., Inc. (NYSE:MRK)\u2019s earnings will also be influenced with this merger almost immediately as they would become more predictable.<\/p>\n<p style=\"text-align: justify;\">The merger, which Merck believes to be \u201cquantum leap\u201d in regards to its life sciences business, is the latest such instance of consolidation among developers of lab testing materials. In 2013, <strong>Thermo Fisher Scientific Inc. (NYSE:TMO)<\/strong> offered $13.6 billion to acquire <strong>Life Technologies Corp (NASDAQ:LIFE)<\/strong>, sigma-Aldrich\u2019s competitor.<\/p>\n<p style=\"text-align: justify;\">In view of some analysts, after acquiring Sigma-Aldrich, Merck &amp; Co., Inc. (NYSE:MRK) will be in a better position against rivals in the pharmaceutical business. Most pharmaceutical companies have recently cut down on the number of suppliers, as an effort to reduce expenses.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 Merck &amp; Co., Inc. (NYSE:MRK), the Germany-based pharmaceutical company, has offered to buy Sigma-Aldrich Corporation (NASDAQ:SIAL) for $17 billion. Terms [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":15692,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[9535,9534,1683,3273,9536,9532,1123,4630,9531,9530,9533,4629],"stock_ticker":[],"class_list":["post-31801","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-life-technologies-corp","tag-life-technologies-corp-nasdaqlife","tag-merck-co-inc-nysemrk","tag-merck-co-inc","tag-nasdaqlife","tag-nasdaqsial","tag-nysemrk","tag-nysetmo","tag-sigma-aldrich-corporation","tag-sigma-aldrich-corporation-nasdaqsial","tag-thermo-fisher-scientific-inc","tag-thermo-fisher-scientific-inc-nysetmo","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck &amp; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck &amp; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 Merck &amp; Co., Inc. (NYSE:MRK), the Germany-based pharmaceutical company, has offered to buy Sigma-Aldrich Corporation (NASDAQ:SIAL) for $17 billion. Terms [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-23T14:50:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Merck &#038; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL)\",\"datePublished\":\"2014-09-23T14:50:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\"},\"wordCount\":354,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"keywords\":[\"Life Technologies Corp\",\"Life Technologies Corp (NASDAQ:LIFE)\",\"Merck &amp; Co Inc. (NYSE:MRK)\",\"Merck &amp; Co. Inc.\",\"NASDAQ:LIFE\",\"NASDAQ:SIAL\",\"NYSE:MRK\",\"NYSE:TMO\",\"Sigma-Aldrich Corporation\",\"Sigma-Aldrich Corporation (NASDAQ:SIAL)\",\"Thermo Fisher Scientific Inc.\",\"Thermo Fisher Scientific Inc. (NYSE:TMO)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\",\"name\":\"Merck & Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"datePublished\":\"2014-09-23T14:50:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"width\":1024,\"height\":750},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck &#038; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck & Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801","og_locale":"en_US","og_type":"article","og_title":"Merck & Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL) - Wall Street PR","og_description":"Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 Merck &amp; Co., Inc. (NYSE:MRK), the Germany-based pharmaceutical company, has offered to buy Sigma-Aldrich Corporation (NASDAQ:SIAL) for $17 billion. Terms [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-23T14:50:01+00:00","og_image":[{"width":1024,"height":750,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Merck &#038; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL)","datePublished":"2014-09-23T14:50:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801"},"wordCount":354,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","keywords":["Life Technologies Corp","Life Technologies Corp (NASDAQ:LIFE)","Merck &amp; Co Inc. (NYSE:MRK)","Merck &amp; Co. Inc.","NASDAQ:LIFE","NASDAQ:SIAL","NYSE:MRK","NYSE:TMO","Sigma-Aldrich Corporation","Sigma-Aldrich Corporation (NASDAQ:SIAL)","Thermo Fisher Scientific Inc.","Thermo Fisher Scientific Inc. (NYSE:TMO)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801","url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801","name":"Merck & Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","datePublished":"2014-09-23T14:50:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","width":1024,"height":750},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-loses-pressure-on-pharmaceutical-unit-by-acquiring-sigma-aldrich-corporation-nasdaqsial-31801#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Merck &#038; Co., Inc. (NYSE:MRK) Loses Pressure On Pharmaceutical Unit By Acquiring Sigma-Aldrich Corporation (NASDAQ:SIAL)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=31801"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31801\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/15692"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=31801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=31801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=31801"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=31801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}